Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Receptor for advanced glycation end products Glycine 82 Serine polymorphism and risk of cardiovascular events in rheumatoid arthritis.
Carroll L, Frazer IH, Turner M, Marwick TH, Thomas R
Arthritis Res Ther 2007, 9:R39
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research article    
Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis
Chen YS, Yan W, Geczy CL, Brown MA, Thomas R
Arthritis Research & Therapy 2009, 11:R39 (11 March 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
2.


Research article    
Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation
Hannawi S, Haluska B, Marwick TH, Thomas R
Arthritis Research & Therapy 2007, 9:R116 (6 November 2007)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.